NCBI Summary
SIGLECs are members of the immunoglobulin superfamily that are expressed on the cell surface. Most SIGLECs have 1 or more cytoplasmic immune receptor tyrosine-based inhibitory motifs, or ITIMs. SIGLECs are typically expressed on cells of the innate immune system, with the exception of the B-cell expressed SIGLEC6 (MIM 604405).[supplied by OMIM, Jul 2002].
Protein
Protein (NP_149121)
SIGLEC-10
Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Siglec-like protein 2)
SIGLEC10
sialic acid binding Ig like lectin 10
Undefined
Curated
I-type lectin
I-Type Lectins - CD33-related Siglecs
b-sandwich / Ig-like
NeuAc / Neu5Ac(a2-6)Gal(b1-4)GlcNAc
0.516
MLLPLLLSSLLGGSQAMDGRFWIRVQESVMVPEGLCISVPCSFSYPRQDWTGSTPAYGYWFKAVTETTKGAPVATNHQSREVEMSTRGRFQLTGDPAKGNCSLVIRDAQMQDESQYFFRVERGSYVRYNFMNDGFFLKVTALTQKPDVYIPETLEPGQPVTVICVFNWAFEECPPPSFSWTGAALSSQGTKPTTSHFSVLSFTPRPQDHNTDLTCHVDFSRKGVSAQRTVRLRVAYAPRDLVISISRDNTPALEPQPQGNVPYLEAQKGQFLRLLCAADSQPPATLSWVLQNRVLSSSHPWGPRPLGLELPGVKAGDSGRYTCRAENRLGSQQRALDLSVQYPPENLRVMVSQANRTVLENLGNGTSLPVLEGQSLCLVCVTHSSPPARLSWTQRGQVLSPSQPSDPGVLELPRVQVEHEGEFTCHARHPLGSQHVSLSLSVHYSPKLLGPSCSWEAEGLHCSCSSQASPAPSLRWWLGEELLEGNSSQDSFEVTPSSAGPWANSSLSLHGGLSSGLRLRCEAWNVHGAQSGSILQLPDKKGLISTAFSNGAFLGIGITALLFLCLALIIMKILPKRRTQTETPRPRFSRHSTILDYINVVPTAGPLAQKRNQKATPNSPRTPLPPGAPSPESKKNQKKQYQLPSFPEPKSSTQAPESQESQEELHYATLNFPGVRPRPEARMPKGTQADYAEVKFQ
No structure currently available in the PDB RCSB Databank.
Structural models
SWISS-MODEL structural models
The location of the lectin domain structural model is: 18-146
We infer [1.26, 1.53] Å as the interval of error of this structural model.
Template 1: 2N7B chain: A, Q9NYZ4, NP_055257.2, sequence identity: 48.8%, coverage: 94.6%, location in sequence: 26-152, (10-136 in PDB).
Template 2: 2ZG1 chain: A, O15389, NP_003821.1, sequence identity: 47.3%, coverage: 94.6%, location in sequence: 20-141, (25-146 in PDB).
Template 3: 6D4A chain: B, P20138, NP_001763.3, sequence identity: 45.0%, coverage: 96.1%, location in sequence: 18-141, (18-141 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
We infer [1.26, 1.53] Å as the interval of error of this structural model.
Template 1: 2N7B chain: A, Q9NYZ4, NP_055257.2, sequence identity: 48.8%, coverage: 94.6%, location in sequence: 26-152, (10-136 in PDB).
Template 2: 2ZG1 chain: A, O15389, NP_003821.1, sequence identity: 47.3%, coverage: 94.6%, location in sequence: 20-141, (25-146 in PDB).
Template 3: 6D4A chain: B, P20138, NP_001763.3, sequence identity: 45.0%, coverage: 96.1%, location in sequence: 18-141, (18-141 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (10 PubMed Identifiers)
- Novel insights into the function of CD24: A driving force in cancer. [32790899]
- Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins. [32915505]
- Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10. [32765491]
- Siglec-10 expression is up-regulated in activated human CD4+ T cells. [32046870]
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. [31367043]
- Violating the splicing rules: TG dinucleotides function as alternative 3' splice sites in U2-dependent introns. [17672918]
- Cloning of two new splice variants of Siglec-10 and mapping of the interaction between Siglec-10 and SHP-1. [12163025]
- Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells. [11358961]
- Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants. [11409878]
- Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. [11284738]
UniProt Main References (6 PubMed Identifiers)
- The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. [12975309]
- Complete sequencing and characterization of 21,243 full-length human cDNAs. [14702039]
- The DNA sequence and biology of human chromosome 19. [15057824]
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
- CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. [19264983]
- Siglec-10 is associated with survival and natural killer cell dysfunction in hepatocellular carcinoma. [25450598]
All isoforms of this gene containing a lectin domain
RNA
RNA (Transcript ID: NM_033130.5)
sialic acid binding Ig like lectin 10, transcript variant 1
m7G-5')ppp(5'-ACUCACAGCACGACCAGAGAACAGGCCUGUCUCAGGCAGGCCCUGCGCCUCCUAUGCGGAGAUGCUACUGCCACUGCUGCUGUCCUCGCUGCUGGGCGGGUCCCAGGCUAUGGAUGGGAGAUUCUGGAUACGAGUGCAGGAGUCAGUGAUGGUGCCGGAGGGCCUGUGCAUCUCUGUGCCCUGCUCUUUCUCCUACCCCCGACAGGACUGGACAGGGUCUACCCCAGCUUAUGGCUACUGGUUCAAAGCAGUGACUGAGACAACCAAGGGUGCUCCUGUGGCCACAAACCACCAGAGUCGAGAGGUGGAAAUGAGCACCCGGGGCCGAUUCCAGCUCACUGGGGAUCCCGCCAAGGGGAACUGCUCCUUGGUGAUCAGAGACGCGCAGAUGCAGGAUGAGUCACAGUACUUCUUUCGGGUGGAGAGAGGAAGCUAUGUGAGAUAUAAUUUCAUGAACGAUGGGUUCUUUCUAAAAGUAACAGCCCUGACUCAGAAGCCUGAUGUCUACAUCCCCGAGACCCUGGAGCCCGGGCAGCCGGUGACGGUCAUCUGUGUGUUUAACUGGGCCUUUGAGGAAUGUCCACCCCCUUCUUUCUCCUGGACGGGGGCUGCCCUCUCCUCCCAAGGAACCAAACCAACGACCUCCCACUUCUCAGUGCUCAGCUUCACGCCCAGACCCCAGGACCACAACACCGACCUCACCUGCCAUGUGGACUUCUCCAGAAAGGGUGUGAGCGCACAGAGGACCGUCCGACUCCGUGUGGCCUAUGCCCCCAGAGACCUUGUUAUCAGCAUUUCACGUGACAACACGCCAGCCCUGGAGCCCCAGCCCCAGGGAAAUGUCCCAUACCUGGAAGCCCAAAAAGGCCAGUUCCUGCGGCUCCUCUGUGCUGCUGACAGCCAGCCCCCUGCCACACUGAGCUGGGUCCUGCAGAACAGAGUCCUCUCCUCGUCCCAUCCCUGGGGCCCUAGACCCCUGGGGCUGGAGCUGCCCGGGGUGAAGGCUGGGGAUUCAGGGCGCUACACCUGCCGAGCGGAGAACAGGCUUGGCUCCCAGCAGCGAGCCCUGGACCUCUCUGUGCAGUAUCCUCCAGAGAACCUGAGAGUGAUGGUUUCCCAAGCAAACAGGACAGUCCUGGAAAACCUUGGGAACGGCACGUCUCUCCCAGUACUGGAGGGCCAAAGCCUGUGCCUGGUCUGUGUCACACACAGCAGCCCCCCAGCCAGGCUGAGCUGGACCCAGAGGGGACAGGUUCUGAGCCCCUCCCAGCCCUCAGACCCCGGGGUCCUGGAGCUGCCUCGGGUUCAAGUGGAGCACGAAGGAGAGUUCACCUGCCACGCUCGGCACCCACUGGGCUCCCAGCACGUCUCUCUCAGCCUCUCCGUGCACUACUCCCCGAAGCUGCUGGGCCCCUCCUGCUCCUGGGAGGCUGAGGGUCUGCACUGCAGCUGCUCCUCCCAGGCCAGCCCGGCCCCCUCUCUGCGCUGGUGGCUUGGGGAGGAGCUGCUGGAGGGGAACAGCAGCCAGGACUCCUUCGAGGUCACCCCCAGCUCAGCCGGGCCCUGGGCCAACAGCUCCCUGAGCCUCCAUGGAGGGCUCAGCUCCGGCCUCAGGCUCCGCUGUGAGGCCUGGAACGUCCAUGGGGCCCAGAGUGGAUCCAUCCUGCAGCUGCCAGAUAAGAAGGGACUCAUCUCAACGGCAUUCUCCAACGGAGCGUUUCUGGGAAUCGGCAUCACGGCUCUUCUUUUCCUCUGCCUGGCCCUGAUCAUCAUGAAGAUUCUACCGAAGAGACGGACUCAGACAGAAACCCCGAGGCCCAGGUUCUCCCGGCACAGCACGAUCCUGGAUUACAUCAAUGUGGUCCCGACGGCUGGCCCCCUGGCUCAGAAGCGGAAUCAGAAAGCCACACCAAACAGUCCUCGGACCCCUCUUCCACCAGGUGCUCCCUCCCCAGAAUCAAAGAAGAACCAGAAAAAGCAGUAUCAGUUGCCCAGUUUCCCAGAACCCAAAUCAUCCACUCAAGCCCCAGAAUCCCAGGAGAGCCAAGAGGAGCUCCAUUAUGCCACGCUCAACUUCCCAGGCGUCAGACCCAGGCCUGAGGCCCGGAUGCCCAAGGGCACCCAGGCGGAUUAUGCAGAAGUCAAGUUCCAAUGAGGGUCUCUUAGGCUUUAGGACUGGGACUUCGGCUAGGGAGGAAGGUAGAGUAAGAGGUUGAAGAUAACAGAGUGCAAAGUUUCCUUCUCUCCCUCUCUCUCUCUCUUUCUCUCUCUCUCUCUCUUUCUCUCUCUUUUAAAAAAACAUCUGGCCAGGGCACAGUGGCUCACGCCUGUAAUCCCAGCACUUUGGGAGGUUGAGGUGGGCAGAUCGCCUGAGGUCGGGAGUUCGAGACCAGCCUGGCCAACUUGGUGAAACCCCGUCUCUACUAAAAAUACAAAAAUUAGCUGGGCAUGGUGGCAGGCGCCUGUAAUCCUACCUACUUGGGAAGCUGAGGCAGGAGAAUCACUUGAACCUGGGAGACGGAGGUUGCAGUGAGCCAAGAUCACACCAUUGCACGCCAGCCUGGGCAACAAAGCGAGACUCCAUCUCAAAAAAAAAAUCCUCCAAAUGGGUUGGGUGUCUGUAAUCCCAGCACUUUGGGAGGCUAAGGUGGGUGGAUUGCUUGAGCCCAGGAGUUCGAGACCAGCCUGGGCAACAUGGUGAAACCCCAUCUCUACAAAAAAUACAAAACAUAGCUGGGCUUGGUGGUGUGUGCCUGUAGUCCCAGCUGUCAGACAUUUAAACCAGAGCAACUCCAUCUGGAAUAGGAGCUGAAUAAAAUGAGGCUGAGACCUACUGGGCUGCAUUCUCAGACAGUGGAGGCAUUCUAAGUCACAGGAUGAGACAGGAGGUCCGUACAAGAUACAGGUCAUAAAGACUUUGCUGAUAAAACAGAUUGCAGUAAAGAAGCCAACCAAAUCCCACCAAAACCAAGUUGGCCACGAGAGUGACCUCUGGUCGUCCUCACUGCUACACUCCUGACAGCACCAUGACAGUUUACAAAUGCCAUGGCAACAUCAGGAAGUUACCCGAUAUGUCCCAAAAGGGGGAGGAAUGAAUAAUCCACCCCUUGUUUAGCAAAUAAGCAAGAAAUAACCAUAAAAGUGGGCAACCAGCAGCUCUAGGCGCUGCUCUUGUCUAUGGAGUAGCCAUUCUUUUGUUCCUUUACUUUCUUAAUAAACUUGCUUUCACCUUAC-3'- Poly-A tail
- Coding region
DNA
DNA (Gene ID: 89790)
sialic acid binding Ig like lectin 10
strand -
SIGLEC-10, SLG2, PRO940, MGC126774
NCBI CDS gene sequence (2094 bp)
5'-ATGCTACTGCCACTGCTGCTGTCCTCGCTGCTGGGCGGGTCCCAGGCTATGGATGGGAGATTCTGGATACGAGTGCAGGAGTCAGTGATGGTGCCGGAGGGCCTGTGCATCTCTGTGCCCTGCTCTTTCTCCTACCCCCGACAGGACTGGACAGGGTCTACCCCAGCTTATGGCTACTGGTTCAAAGCAGTGACTGAGACAACCAAGGGTGCTCCTGTGGCCACAAACCACCAGAGTCGAGAGGTGGAAATGAGCACCCGGGGCCGATTCCAGCTCACTGGGGATCCCGCCAAGGGGAACTGCTCCTTGGTGATCAGAGACGCGCAGATGCAGGATGAGTCACAGTACTTCTTTCGGGTGGAGAGAGGAAGCTATGTGAGATATAATTTCATGAACGATGGGTTCTTTCTAAAAGTAACAGCCCTGACTCAGAAGCCTGATGTCTACATCCCCGAGACCCTGGAGCCCGGGCAGCCGGTGACGGTCATCTGTGTGTTTAACTGGGCCTTTGAGGAATGTCCACCCCCTTCTTTCTCCTGGACGGGGGCTGCCCTCTCCTCCCAAGGAACCAAACCAACGACCTCCCACTTCTCAGTGCTCAGCTTCACGCCCAGACCCCAGGACCACAACACCGACCTCACCTGCCATGTGGACTTCTCCAGAAAGGGTGTGAGCGCACAGAGGACCGTCCGACTCCGTGTGGCCTATGCCCCCAGAGACCTTGTTATCAGCATTTCACGTGACAACACGCCAGCCCTGGAGCCCCAGCCCCAGGGAAATGTCCCATACCTGGAAGCCCAAAAAGGCCAGTTCCTGCGGCTCCTCTGTGCTGCTGACAGCCAGCCCCCTGCCACACTGAGCTGGGTCCTGCAGAACAGAGTCCTCTCCTCGTCCCATCCCTGGGGCCCTAGACCCCTGGGGCTGGAGCTGCCCGGGGTGAAGGCTGGGGATTCAGGGCGCTACACCTGCCGAGCGGAGAACAGGCTTGGCTCCCAGCAGCGAGCCCTGGACCTCTCTGTGCAGTATCCTCCAGAGAACCTGAGAGTGATGGTTTCCCAAGCAAACAGGACAGTCCTGGAAAACCTTGGGAACGGCACGTCTCTCCCAGTACTGGAGGGCCAAAGCCTGTGCCTGGTCTGTGTCACACACAGCAGCCCCCCAGCCAGGCTGAGCTGGACCCAGAGGGGACAGGTTCTGAGCCCCTCCCAGCCCTCAGACCCCGGGGTCCTGGAGCTGCCTCGGGTTCAAGTGGAGCACGAAGGAGAGTTCACCTGCCACGCTCGGCACCCACTGGGCTCCCAGCACGTCTCTCTCAGCCTCTCCGTGCACTACTCCCCGAAGCTGCTGGGCCCCTCCTGCTCCTGGGAGGCTGAGGGTCTGCACTGCAGCTGCTCCTCCCAGGCCAGCCCGGCCCCCTCTCTGCGCTGGTGGCTTGGGGAGGAGCTGCTGGAGGGGAACAGCAGCCAGGACTCCTTCGAGGTCACCCCCAGCTCAGCCGGGCCCTGGGCCAACAGCTCCCTGAGCCTCCATGGAGGGCTCAGCTCCGGCCTCAGGCTCCGCTGTGAGGCCTGGAACGTCCATGGGGCCCAGAGTGGATCCATCCTGCAGCTGCCAGATAAGAAGGGACTCATCTCAACGGCATTCTCCAACGGAGCGTTTCTGGGAATCGGCATCACGGCTCTTCTTTTCCTCTGCCTGGCCCTGATCATCATGAAGATTCTACCGAAGAGACGGACTCAGACAGAAACCCCGAGGCCCAGGTTCTCCCGGCACAGCACGATCCTGGATTACATCAATGTGGTCCCGACGGCTGGCCCCCTGGCTCAGAAGCGGAATCAGAAAGCCACACCAAACAGTCCTCGGACCCCTCTTCCACCAGGTGCTCCCTCCCCAGAATCAAAGAAGAACCAGAAAAAGCAGTATCAGTTGCCCAGTTTCCCAGAACCCAAATCATCCACTCAAGCCCCAGAATCCCAGGAGAGCCAAGAGGAGCTCCATTATGCCACGCTCAACTTCCCAGGCGTCAGACCCAGGCCTGAGGCCCGGATGCCCAAGGGCACCCAGGCGGATTATGCAGAAGTCAAGTTCCAATGA-3'
By using this site you agree to our privacy policy.
Please confirm you agree with the privacy policy before using the site.